...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith funding???

...also in today’s WSJ...”Pfizer Chief Financial Officer, Frank D’Amelio told analysts on a conference call the company will continue to search for small and midsize deal and isn’t dependent on larger acquisitions for Growth.

Well, Frank.....”Take a look at Zenith...you’ve been in a joint venture trial for quite a while now...you must have uncovered something. Our CEO says that we’re beyond awesome with our science... take a look Frank...sooner rather than later!

Share
New Message
Please login to post a reply